PAMP
LEGN icon

Polar Asset Management Partners’s Legend Biotech LEGN Stock Holding History

Polar Asset Management Partners’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-107,700
Closed -$3.82M – 749
2025
Q2 		$3.82M Buy
107,700
+88,988
+476% +$2.88M 0.06% 236
2025
Q1 		$635K Sell
18,712
-5,926
-24% -$213K 0.01% 327
2024
Q4 		$802K Buy
24,638
+9,779
+66% +$405K 0.01% 457
2024
Q3 		$724K Sell
14,859
-220,200
-94% -$11.7M 0.02% 443
2024
Q2 		$10.4M Buy
235,059
+198,159
+537% +$9.14M 0.22% 98
2024
Q1 		$2.07M Sell
36,900
-14,500
-28% -$874K 0.04% 358
2023
Q4 		$3.09M Buy
51,400
+35,700
+227% +$2.26M 0.05% 305
2023
Q3 		$1.05M Hold
15,700
– – 0.02% 452
2023
Q2 		$1.08M Sell
15,700
-193,800
-93% -$12.7M 0.02% 505
2023
Q1 		$10.1M Sell
209,500
-21,300
-9% -$1.04M 0.15% 191
2022
Q4 		$11.5M Sell
230,800
-100
-0% -$4.84K 0.14% 197
2022
Q3 		$9.42M Buy
+230,900
New +$10.8M 0.11% 287

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Polar Asset Management Partners's LEGN Position: Q3 2025 in Review

Polar Asset Management Partners sold out of Legend Biotech (LEGN) in Q3 2025, closing a stake of 107,700 shares — an estimated $3.82M sold.

Polar Asset Management Partners first reported a position in LEGN in Q3 2022 and held it in 12 quarters. The position peaked at $11.5M in Q4 2022. 200 funds tracked by Wall St. Rank hold LEGN as of Q3 2025.

  • Polar Asset Management Partners reported no remaining Legend Biotech position as of Q3 2025 after selling out during the quarter.
  • Polar Asset Management Partners sold 107,700 Legend Biotech shares in Q3 2025, an estimated $3.82M.
  • Polar Asset Management Partners first reported a position in Legend Biotech in Q3 2022 and held it in 12 quarters.
  • Polar Asset Management Partners's Legend Biotech position peaked at $11.5M in Q4 2022.
  • 200 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2025.

Based on Polar Asset Management Partners's 13F filing for Q3 2025, filed 14 Nov 2025.